Myriad Genetics Stock Price and Value Analysis

Should you buy Myriad Genetics stock? (NasdaqGS:MYGN). Let's see how it does in our automated value investing analysis system.

MYGN Free Cash Flow Trend

Free Cash Flow trendline for MYGN
Free Cash Flow trendline for Myriad Genetics

Based on historical returns, we believe that Myriad Genetics can grow its free cash at a rate of about 5%. That's positive!

  • This company has fluctuating growth.
  • This stock is on sale.
  • This company is making money at a decent rate.
  • This company is less known than others.
  • This company pays no dividend.

Inside the MYGN Numbers

MYGN Price
(Myriad Genetics stock price per share)
MYGN Fair Price
(based on intrinsic value)
MYGN Safety Price (based on a variable margin of safety) $16.24
PE Ratio versus Sector 1984% higher than other Healthcare stocks
PE Ratio versus Industry 49% lower than other Diagnostics & Research stocks
Cash Yield 7.54%
Free Cash Flow Jitter 26%

Is Myriad Genetics Stock on Sale?

We believe that Myriad Genetics may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Myriad Genetics looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Should You Buy MYGN Stock?

Does Myriad Genetics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.